We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VXUS icon
301
Vanguard Total International Stock ETF
VXUS
$160B
$326K ﹤0.01%
6,625
– –
CI icon
302
Cigna
CI
$74.6B
$322K ﹤0.01%
1,714
-331
-16% -$62.8K
CFR icon
303
Cullen/Frost Bankers
CFR
$10.2B
$299K ﹤0.01%
4,000
-64
-2% -$4.46K
DLTR icon
304
Dollar Tree
DLTR
$25.2B
$297K ﹤0.01%
3,200
– –
BIP icon
305
Brookfield Infrastructure Partners
BIP
$18B
$284K ﹤0.01%
10,350
– –
NVDA icon
306
NVIDIA
NVDA
$5.42T
$274K ﹤0.01%
+28,840
New +$233K
BABA icon
307
Alibaba
BABA
$308B
$268K ﹤0.01%
+1,243
New +$259K
CMD
308
DELISTED
Cantel Medical Corporation
CMD
$258K ﹤0.01%
5,835
-30,034
-84% -$1.12M
ADBE icon
309
Adobe
ADBE
$105B
$254K ﹤0.01%
+583
New +$216K
EEM icon
310
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$253K ﹤0.01%
6,326
– –
SCHW
311
Charles Schwab
SCHW
$187B
$253K ﹤0.01%
7,505
-350
-4% -$12.5K
DAL icon
312
Delta Air Lines
DAL
$60.1B
$247K ﹤0.01%
+8,800
New +$224K
HPE icon
313
Hewlett Packard
HPE
$70.5B
$232K ﹤0.01%
23,869
-3,200
-12% -$31.4K
VSS icon
314
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$230K ﹤0.01%
+2,384
New +$213K
CHKP icon
315
Check Point Software Technologies
CHKP
$13.1B
$226K ﹤0.01%
2,100
– –
AMAT icon
316
Applied Materials
AMAT
$428B
$224K ﹤0.01%
+3,700
New +$200K
TROW icon
317
T. Rowe Price
TROW
$24.3B
$212K ﹤0.01%
+1,716
New +$196K
YUM icon
318
Yum! Brands
YUM
$41.1B
$206K ﹤0.01%
+2,376
New +$203K
ZBRA icon
319
Zebra Technologies
ZBRA
$17.8B
$205K ﹤0.01%
+800
New +$187K
LCNB icon
320
LCNB Corp
LCNB
$283M
$172K ﹤0.01%
10,800
– –
LYTS icon
321
LSI Industries
LYTS
$924M
$169K ﹤0.01%
26,121
– –
PLUG icon
322
Plug Power
PLUG
$3.04B
$133K ﹤0.01%
16,233
-700
-4% -$3.28K
ET icon
323
Energy Transfer Partners
ET
$69.3B
$112K ﹤0.01%
15,680
– –
NOK icon
324
Nokia
NOK
$52.3B
$96K ﹤0.01%
21,900
– –
BIIB icon
325
Biogen
BIIB
$30.7B
– –
-652
Closed -$206K
10 11 12
13
14

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.